{"result": "(\"entity\"<|>LEPROSY<|>EVENT<|>Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae, characterized by skin lesions and nerve damage.)\n##\n(\"entity\"<|>RIFAMPICIN<|>ORGANIZATION<|>Rifampicin is an antibiotic used to treat leprosy, belonging to the pharmacologic class of Rifamycins.)\n##\n(\"entity\"<|>DAPSONE<|>ORGANIZATION<|>Dapsone is a medication used to treat leprosy, classified as a Sulfone, with various side effects including abdominal pain and renal issues.)\n##\n(\"entity\"<|>THALIDOMIDE<|>ORGANIZATION<|>Thalidomide is a drug used to treat leprosy, known for its immunomodulatory effects and associated with multiple side effects.)\n##\n(\"entity\"<|>AGEUSIA<|>EVENT<|>Ageusia is a symptom characterized by the loss of taste, which can be associated with leprosy.)\n##\n(\"entity\"<|>BLINDNESS<|>EVENT<|>Blindness is a symptom that can occur in patients with leprosy due to nerve damage.)\n##\n(\"entity\"<|>EDEMA<|>EVENT<|>Edema is a symptom involving swelling caused by fluid retention, which can be present in leprosy patients.)\n##\n(\"entity\"<|>EYE MANIFESTATIONS<|>EVENT<|>Eye manifestations refer to various eye-related symptoms that can occur in leprosy patients.)\n##\n(\"entity\"<|>FACIAL PARALYSIS<|>EVENT<|>Facial paralysis is a symptom of leprosy that results from nerve damage affecting facial muscles.)\n##\n(\"entity\"<|>FEVER<|>EVENT<|>Fever is a common symptom that can occur in leprosy patients as part of the body's response to infection.)\n##\n(\"entity\"<|>HYPERESTHESIA<|>EVENT<|>Hyperesthesia is a condition of increased sensitivity to sensory stimuli, which can be experienced by leprosy patients.)\n##\n(\"entity\"<|>HYPOESTHESIA<|>EVENT<|>Hypoesthesia is a condition of reduced sensitivity to sensory stimuli, often seen in leprosy due to nerve damage.)\n##\n(\"entity\"<|>MUSCULAR ATROPHY<|>EVENT<|>Muscular atrophy refers to the wasting away of muscle tissue, which can occur in leprosy patients due to nerve damage.)\n##\n(\"entity\"<|>NEURALGIA<|>EVENT<|>Neuralgia is a symptom characterized by sharp pain along the path of a nerve, which can be associated with leprosy.)\n##\n(\"entity\"<|>NOSE<|>GEO<|>The nose is a part of the human body where leprosy can localize, leading to deformities and damage.)\n##\n(\"entity\"<|>PERIPHERAL NERVOUS SYSTEM<|>GEO<|>The peripheral nervous system is affected by leprosy, leading to symptoms such as loss of sensation and muscle weakness.)\n##\n(\"entity\"<|>APPENDAGE<|>GEO<|>Appendages, such as hands and feet, can be affected by leprosy, resulting in deformities and loss of function.)\n##\n(\"entity\"<|>TENDON<|>GEO<|>Tendons can be impacted by leprosy, leading to complications in movement and function.)\n##\n(\"entity\"<|>TESTIS<|>GEO<|>The testis is a part of the human body where leprosy can localize, potentially affecting reproductive health.)\n##\n(\"entity\"<|>EYE<|>GEO<|>The eye is a part of the human body that can be affected by leprosy, leading to vision problems.)\n##\n(\"entity\"<|>SKIN EPIDERMIS<|>GEO<|>The skin epidermis is the outer layer of skin that is often affected by leprosy, leading to lesions and deformities.)\n##\n(\"entity\"<|>NERVOUS SYSTEM<|>GEO<|>The nervous system is significantly impacted by leprosy, resulting in various neurological symptoms.)\n##\n(\"entity\"<|>NERVE<|>GEO<|>Nerves can be damaged by leprosy, leading to loss of sensation and muscle control.)\n##\n(\"entity\"<|>SHEATH OF SCHWANN<|>GEO<|>The sheath of Schwann is a protective covering of nerves that can be affected by leprosy, impacting nerve function.)\n##\n(\"relationship\"<|>LEPROSY<|>RIFAMPICIN<|>Rifampicin is used to treat leprosy, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>LEPROSY<|>DAPSONE<|>Dapsone is used to treat leprosy, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>LEPROSY<|>THALIDOMIDE<|>Thalidomide is used to treat leprosy, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>LEPROSY<|>AGEUSIA<|>Ageusia is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>BLINDNESS<|>Blindness is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>EDEMA<|>Edema is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>EYE MANIFESTATIONS<|>Eye manifestations are symptoms associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>FACIAL PARALYSIS<|>Facial paralysis is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>FEVER<|>Fever is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>HYPERESTHESIA<|>Hyperesthesia is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>HYPOESTHESIA<|>Hypoesthesia is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>MUSCULAR ATROPHY<|>Muscular atrophy is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>NEURALGIA<|>Neuralgia is a symptom associated with leprosy, indicating a direct relationship<|>7)\n##\n(\"relationship\"<|>LEPROSY<|>NOSE<|>Leprosy can localize at the nose, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>PERIPHERAL NERVOUS SYSTEM<|>Leprosy can localize at the peripheral nervous system, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>APPENDAGE<|>Leprosy can localize at appendages, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>TENDON<|>Leprosy can localize at tendons, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>TESTIS<|>Leprosy can localize at the testis, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>EYE<|>Leprosy can localize at the eye, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>SKIN EPIDERMIS<|>Leprosy can localize at the skin epidermis, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>NERVOUS SYSTEM<|>Leprosy can localize at the nervous system, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>NERVE<|>Leprosy can localize at nerves, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>LEPROSY<|>SHEATH OF SCHWANN<|>Leprosy can localize at the sheath of Schwann, indicating a direct relationship<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: [Leprosy] is the name of a kind of disease.\n[Leprosy] presents the symptom [Ageusia].\n[Leprosy] presents the symptom [Blindness].\n[Leprosy] presents the symptom [Edema].\n[Leprosy] presents the symptom [Eye Manifestations].\n[Leprosy] presents the symptom [Facial Paralysis].\n[Leprosy] presents the symptom [Fever].\n[Leprosy] presents the symptom [Hyperesthesia].\n[Leprosy] presents the symptom [Hypesthesia].\n[Leprosy] presents the symptom [Muscular Atrophy].\n[Leprosy] presents the symptom [Neuralgia].\n[Leprosy] localizes at the [Nose] of human body.\n[Leprosy] localizes at the [Peripheral Nervous System] of human body.\n[Leprosy] localizes at the [Appendage] of human body.\n[Leprosy] localizes at the [Tendon] of human body.\n[Leprosy] localizes at the [Testis] of human body.\n[Leprosy] localizes at the [Eye] of human body.\n[Leprosy] localizes at the [Skin Epidermis] of human body.\n[Leprosy] localizes at the [Nervous System] of human body.\n[Leprosy] localizes at the [Nerve] of human body.\n[Leprosy] localizes at the [Sheath Of Schwann] of human body.\n\nThe following content describes information about compounds that can palliate or treat the disease named Leprosy.The format of each compound's information is as follows:\nCompound name: ***\nPharmacologic class: ***\nEffect on Leprosy: Palliate or Treat\nSide effect: ***\nThese respectively represent the name of the compound, the pharmacologic class it belongs to, its positive effect on the disease named Leprosy (palliates or treats) and its side effects.\n\nCompound name: Rifampicin\nPharmacologic class: Rifamycins\nEffect on Leprosy: Treat\nSide effect: \n\nCompound name: Dapsone\nPharmacologic class: Sulfones\nEffect on Leprosy: Treat\nSide effect: Abdominal pain, Albuminuria, Anoxia, Cough, Body temperature increased, Headache, Infectious mononucleosis, Infertility male, Influenza, Renal papillary necrosis\n\nCompound name: Thalidomide\nPharmacologic class: Decreased Immunologically Active Molecule Activity\nEffect on Leprosy: Treat\nSide effect: Abdominal distension, Abdominal pain, Multiple congenital abnormalities, Acquired immunodeficiency syndrome, Agranulocytosis, Albuminuria, Alopecia, Amblyopia, Amenorrhoea, Amnesia\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}